￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
The latest progress and research results of domestic clinical trials of vorasidenib-VORANIGO

2026-02-01 22:25:32

Check Details
Correct usage, dosage and dosage adjustment standards of eflornithine (IWILFIN)

2026-02-01 22:25:32

Check Details
The latest domestic approval time and application prospects of odevixibat

2026-02-01 22:25:32

Check Details
Comparison of the mechanism of action and clinical effects of donepezil (Aricept) and rivastigmine

2026-02-01 22:25:32

Check Details
Comprehensive analysis of the drug properties, specifications and packaging information of Fidaxomicin

2026-02-01 22:25:32

Check Details
How to safely use ponatinib and dosage adjustment recommendations in patients with hepatic insufficiency

2026-02-01 22:25:32

Check Details
Whether Trelagliptin can cure diabetes and the actual effect of long-term treatment

2026-02-01 22:25:32

Check Details
Possible side effects of Inalisate (Iheli) and scientific countermeasures

2026-02-01 22:25:32

Check Details
Analysis of how long it takes for Abatacept injection to take effect and how long it lasts

2026-02-01 22:25:32

Check Details
What is the approximate price of a box of acotinib/acabrutinib on the market?

2026-02-01 22:25:32

Check Details
New 10-year data shows ibrutinib/Eco has durable efficacy in CLL/SLL

2026-02-01 22:25:32

Check Details
INCB057643 combined with ruxolitinib tablets/ruxolitinib can improve symptoms in patients with myelofibrosis

2026-02-01 22:25:32

Check Details
Category
相关知识